Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Treatment of Periodontitis by Tulsi Gel [Phase 2, Phase 3]

View source ↗

Summary

Tulsi Gel is being investigated for advanced periodontitis and stage III/IV periodontitis in Phase 2/Phase 3 trials, with recruitment not yet underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tulsi Gel (Ocimum tenuiflorum (holy basil) extract gel)

Snippet

Sponsor: Al-Azhar University | Conditions: Advanced Periodontitis, Stage III Periodontitis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING